Journal of Alzheimer's Disease
Efficacy and safety of aducanumab, lecanemab, and donanemab in Alzheimer's disease: A meta-analysis of randomized controlled trials
Meta-analysis of randomised trialsAlzheimer's disease
Papers by Maheen Shaharyar
1 result